Zaloguj się

Gotowe bibliografie tematyczne / Leukemia Chemotherapy / Książki

Książki na temat „Leukemia Chemotherapy”

Kliknij ten link, aby zobaczyć inne rodzaje publikacji na ten temat: Leukemia Chemotherapy.

Autor: Grafiati

Data publikacji: 4 czerwca 2021

Data aktualizacji: 28 stycznia 2023

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Sprawdź 50 najlepszych książek naukowych na temat „Leukemia Chemotherapy”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Przeglądaj książki z różnych dziedzin i twórz odpowiednie bibliografie.

1

Ueda, Takanori, red. Chemotherapy for Leukemia. Singapore: Springer Singapore, 2017. http://dx.doi.org/10.1007/978-981-10-3332-2.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Schmidt, Carolina Witchmichen Penteado, i Kaléu Mormino Otoni, red. Chemotherapy and Pharmacology for Leukemia in Pregnancy. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-54058-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Heinemann, Volker. Supportive therapy in leukemia patients: Clinical handbook with checklist. Stuttgart ; New York: G. Thieme Verlag ; New York : Thieme Medical Publishers, 1993.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Ludwig, Deborah. Rebirth: A leukemia survivor's journal of healing during chemotherapy, bone marrow transplant and recovery. [Place of publication not identified]: Xlibris Corp., 2009.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

1946-, Cheson Bruce D., Keating Michael J. 1943- i Plunkett William 1943-, red. Nucleoside analogs in cancer therapy. New York: M. Dekker, 1997.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

1951-, Pui Ching-Hon, red. Treatment of acute leukemias: New directions for clinical research. Totowa, N.J: Humana Press, 2003.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Hancock, Sarah. Fludarabine as first line therapy for chronic lymphocytic leukaemia. Birmingham: University of Birmingham, Department of Public Health and Epidemiology, 2003.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Kaspers, G. J. L., 1963-, Pieters R i International Symposium on Drug Resistance in Leukemia and Lymphoma (3rd : 1998 : Amsterdam, Netherlands), red. Drug resistance in leukemia and lymphoma III. New York: Kluwer Academic/Plenum Press, 1999.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Heim, Marcel U. The leukemia patient as a partner in therapy: A guidebook for patients, relatives, nurses, and physicians. Stuttgart: GTV Stuttgart, 1994.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Kaspers, G. J. L., 1963-, red. Drug resistance in leukemia and lymphoma: The clinical value of laboratory studies. Chur, Switzerland: Harwood Academic Publishers, 1993.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

11

W, Hiddemann, red. Acute leukemias: Pharmacokinetics and management of relapsed and refractory disease. Berlin: Springer-Verlag, 1992.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

12

Polliack, Aaron. A handbook of essential drugs and regimens in hematological oncology. Chur: Harwood Academic Publishers, 1991.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

13

Legendre, Ginette. L'histoire de Casse-Tête: La pouliche leucémique. Moncton, N.-B: Éditions de la Francophonie, 2006.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

14

Lyman, Gary H. Chemotherapy for Chronic Lymphocytic Leukemia. Oxford University Press, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

15

Bennett, Lunawati L. Frontiers in Leukemia Pharmacotherapy. Nova Science Publishers, Incorporated, 2019.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

16

Ueda, Takanori. Chemotherapy for Leukemia: Novel Drugs and Treatment. Springer, 2018.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

17

Ueda, Takanori. Chemotherapy for Leukemia: Novel Drugs and Treatment. Springer, 2017.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

18

Ueda, Takanori. Chemotherapy for Leukemia: Novel Drugs and Treatment. Springer, 2017.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

19

Bryson, James Scott. Characteristics of reovirus-mediated chemoimmunotherapy of murine L1210 leukemia. 1985.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

20

Farone, Anthony Louis. Interleukin-2 chemoimmunotherapy of murine L1210 leukemia. 1988.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

21

Farone, Anthony Louis. Interleukin-2 chemoimmunotherapy of murine L1210 leukemia. 1988.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

22

Koenigsberg, Adam David. Alpha/Beta and Gamma interferon responses during reovirus-mediated chemoimmunotherapy of L1210 leukemia. 1988.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

23

Heinemann, Volker, i Ulrich Jehn. Supportive Therapy in Leukemia Patients (Supportive Measures in Oncology). Thieme Publishing Group, 1992.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

24

Kaspers, G. J. L., 1963-, Pieters R i Veerman A. J. P, red. Drug resistance in leukemia and lymphoma II. Amsterdam, the Netherlands: Harwood Academic Publishers, 1997.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

25

Gill, Harinder, Yok Lam Kwong i Farhad Ravandi, red. Acute Promyelocytic Leukemia - Towards a Chemotherapy-Free Approach to Cure in All Patients. Frontiers Media SA, 2022. http://dx.doi.org/10.3389/978-2-88974-475-6.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

26

Schmidt, Carolina Witchmichen Penteado, i Kaléu Mormino Otoni. Chemotherapy and Pharmacology for Leukemia in Pregnancy: Guidelines and Strategies for Best Practices. Springer International Publishing AG, 2020.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

27

Supportive Measures of Oncology. Thieme-Stratton Corp, 1998.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

28

Farone, Anthony L. Characterization of the immune responses during chemoimmunotherapy of murine L1210 leukemia. 1992.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

29

Roman, Eve, Alexandra Smith i Lorelei Mucci. Leukemias. Oxford University Press, 2018. http://dx.doi.org/10.1093/oso/9780190676827.003.0028.

Pełny tekst źródła

Streszczenie:

Leukemias are a diverse group of acute and chronic haematological malignancies, that account for 2% to 3% of cancers globally. Recent advances in molecular biology and therapy have transformed the landscape for several leukemia subtypes changing some, but by no means all, from rapidly fatal diseases to treatable conditions with a good prognosis. In general, however, this progress has not been matched by new aetiological insights. Albeit accounting for a relatively small proportion, genetic predisposition syndromes such as neurofibromatosis, Li-Fraumeni and Trisomy 21, have the biggest impact in children and young adults. At older ages, established chemical, physical and biological risk factors, which explain only a small proportion of the total disease burden, include chemotherapy for a preceding cancer, ionizing radiation, and the viral infections human T-cell lymphotropic virus type 1 (HTLV-1) which causes the rare adult T-cell leukemia/lymphoma (ATLL) and the human immunodeficiency virus (HIV) which is associated with an increased risk of acute lymphoid leukaemias. Workplace exposures to potential carcinogens such as benzene, butadiene, and styrene have also been linked to increased risk of leukemia.

Style APA, Harvard, Vancouver, ISO itp.

30

National Institute for Clinical Excellence. Guidance on the use of fludarabine for B-cell chronic lymphocytic leukaemia. London, 2001.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

31

Haas, David Gerard. Cytotoxic T lymphocyte and natural killer cell responses following chemoimmunotherapy of murine L1210 leukemia. 1986.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

32

Ritter, Jörg, Ursula Creutzig i Günther Schellong. Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies. Springer, 2011.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

33

Ritter, Jörg, Ursula Creutzig i Günther Schellong. Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies. Springer London, Limited, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

34

Creutzig, U., i J. Ritter. Acute Myelogenous Leukemia in Childhood: Implications of Therapy Studies for Future Risk-Adapted Treatment Strategies. Springer, 1990.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

35

1946-, Creutzig U., Ritter Jörg i Schellong Günther, red. Acute myelogenous leukemia in childhood: Implications of therapy studies for future risk-adapted treatment strategies. Berlin: Springer-Verlag, 1990.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

36

Linet, Martha S., Lindsay M. Morton, Susan S. Devesa i Graça M. Dores. Leukemias. Oxford University Press, 2017. http://dx.doi.org/10.1093/oso/9780190238667.003.0038.

Pełny tekst źródła

Streszczenie:

The 2001 World Health Organization (WHO) classification of hematopoietic and lymphoid neoplasms categorized “the leukemias” into two major groupings—myeloid and lymphoid. Myeloid neoplasms, which are the primary focus of this chapter, include acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPN). Lymphoid neoplasms are mostly reviewed as part of non-Hodgkin lymphoma in Chapter 40 of this volume, although descriptive patterns and selected etiologic studies are briefly discussed in this chapter because of historical trends. Worldwide, leukemias are ranked eleventh among all cancer types, comprising approximately 2.5% of all malignancies. Exposure to ionizing radiation and certain chemical carcinogens (e.g., cytotoxic chemotherapy, benzene, formaldehyde) are the most consistently associated risk factors for MDS and/or AML. Radiation has been linked with CML, and cigarette smoking with AML. Fewer risk factors have been identified for MPNs. Some evidence implicates increased risks of AML in rubber workers, farmers, and other agricultural workers.

Style APA, Harvard, Vancouver, ISO itp.

37

1951-, Pui Ching-Hon, red. Treatment of acute leukemias: New directions for clinical research. Totowa, N.J: Humana Press, 2003.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

38

Pui, Ching-Hon. Treatment of Acute Leukemias: New Directions for Clinical Research (Current Clinical Oncology). Humana Press, 2003.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

39

Vehling-Kaiser, Ulla, i Marcel U. Heim. The Leukemia Patient As Partner in Therapy: A Guidebook for Patients, Relatives, Nurses and Physicians (Supportive Measures in Oncology/Import). Thieme Medical Pub, 1994.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

40

Fridbinstons, Pit Alex. Causes of Thrombocytopenia: Enlarged Spleen, Anemia, Leukemia, Pregnancy, Heavy Alcohol Consumption, Viral Infections, Chemotherapy Medications, Hemolytic Uremic Syndrome, Thrombotic Thrombocytopenic Purpura. Independently Published, 2021.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

41

Cheson. Nucleoside Analogs Cancer Therapy (Basic and Clinical Oncology, 12). Informa Healthcare, 1997.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

42

KAS, GERT-JAN L. Drug Resistance in Leukemia and Lymphoma: The Clinical Value of Laboratory Studies. Taylor & Francis, 1993.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

43

Plunkett, W., M. Keating, W. Hiddemann, T. Büchner i B. Wörmann. Acute Leukemias: Pharmacokinetics and Management of Relapsed and Refractory Disease. Springer London, Limited, 2012.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

44

Buchner, T., i W. Hiddemann. Acute Leukemias: Pharmacokinetics and Management of Relapsed and Refractory Disease (Haematologie Und Bluttransfusion). Springer-Verlag, 1992.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

45

Acute Leukaemias (Hamatologie und Bluttransfusion). Springer-Verlag Berlin and Heidelberg GmbH & Co. K, 1992.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

46

1926-, Cacciola E., Deisseroth Albert B. 1941- i Giustolisi R, red. Hemopoietic growth factors, oncogenes, and cytokines in clinical hematology: Current aspects and future directions. Basel: Karger, 1994.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

47

Negative regulators of hematopoiesis: Studies on their nature, action, and potential role in cancer therapy. New York, N.Y: New York Academy of Sciences, 1991.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

48

Najman, Albert, Athanasius Anagnostou i Nicholas Dainiak. Negative regulators of hematopoiesis : Studies on their nature, action, and potential role in cancer therapy. New York Academy of Sciences, 1991.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

49

Athanasius, Anagostou, Dainiak Nicholas, Najman Albert i International Conference on Negative Regulators of Hematopoiesis, (2nd : 1990 : Providence, R.I.), red. Negative regulators of hematopoiesis: Studies of their nature, action, and potential role in cancer therapy. New York, N.Y: New York Academy of Sciences, 1991.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

50

Anagnostou, Athanasius, i Nicholas Dainiak. Negative Regulators of Hematopoiesis: Studies on Their Nature, Action, and Potential Role in Cancer Therapy (Annals of the New York Academy of Scien). New York Academy of Sciences, 1991.

Znajdź pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!